FUBINACA powder is a synthetic chemical compound categorized as a illicit recreational substance or an analytical reference standard for laboratory research. [1, 2, 3]
What is FUBINACA?
- Synthetic Cannabinoid: It is a laboratory-synthesized compound designed to interact with the body’s cannabinoid receptors, mimicking some effects of THC, the main psychoactive component in cannabis. [1, 2]
- High Potency: These synthetic variants are often significantly more potent than naturally occurring cannabinoids. [1, 2]
- Development History: Certain variations were initially generated during pharmaceutical research into pain management, but they have no approved therapeutic or medical use in humans. [1, 2, 3]
Context of Availability
- Illicit Market: On the gray market and street level, these chemical powders are frequently applied to inert herbal materials and marketed under informal names such as “Spice” or “K2”. [1, 2]
- Laboratory Research: In legitimate scientific settings, the high-purity powder is utilized as an analytical reference material to study receptor binding and chemical properties, rather than for human consumption. [1, 2]
Major Risks
- Severe Toxicity: Ingestion or inhalation can lead to severe adverse physiological reactions, including acute cardiovascular distress, severe hypertension, intense anxiety, paranoia, and loss of consciousness. [1, 2]
- High Overdose Potential: Due to the extreme potency and lack of quality control in illicit manufacturing, the risk of accidental overdose or fatal poisoning is high. [1, 2, 3]
- Legal Status: FUBINACA variants are widely classified as controlled substances and are illegal to manufacture, distribute, or possess in many jurisdictions
What is AB-Fubinaca?
AB-FUBINACA is a potent synthetic cannabinoid that acts as a strong agonist (activator) for human brain cannabinoid receptors. Wikipedia +1
History and Origin
- Pfizer Development: Created by pharmaceutical company Pfizer in 2009 as an experimental pain-relief medication (analgesic).
- Human Use Dropped: Never tested or approved for human medical use.
- Recreational Market: First found in Japan in 2012 as an active chemical additive in illegal herbal incense or “Spice”/”K2” products.
Cayman Chemical +2
Effects and Risks
- Receptor Binding: Binds tightly to CB1 and CB2 receptors, producing much stronger psychoactive effects than natural cannabis.
- Physical Impacts: Causes severe hypothermia, slow movement, loss of balance, and tremors in laboratory testing.
- Health Dangers: Associated with severe poisonings, emergency room visits, and fatalities due to unpredictable toxicity.
National Institutes of Health (NIH) | (.gov) +2
Legal Status
- United States: Classified as a Schedule I controlled substance, meaning it has a high potential for abuse and no accepted medical use.